What is MECP2 Duplication Syndrome

MECP2 Duplication Syndrome is a rare, X-linked genetic disorder caused by having an extra copy of the MECP2 gene, which leads to severe intellectual disability, developmental delays, and recurrent infections. This condition predominantly affects males and is characterized by a spectrum of neurological and physical challenges that require lifelong multidisciplinary medical care.

What causes MECP2 Duplication Syndrome?

MECP2 Duplication Syndrome occurs when an individual has a duplication of the MECP2 gene located on the X chromosome. This gene produces a protein essential for brain function. Because the body cannot properly regulate this excess protein, the development of the nervous system is disrupted. Unlike Rett syndrome, which is caused by a mutation or loss of the MECP2 gene, MECP2 Duplication Syndrome is caused by the presence of too much of the gene’s product.

Who is affected by MECP2 Duplication Syndrome?

This condition is extremely rare, with fewer than 500 cases reported in medical literature worldwide, though it is likely underdiagnosed. It almost exclusively affects males because the gene is located on the X chromosome; while females carry the duplication, they are usually asymptomatic because they possess a second, normal X chromosome that compensates for the duplication. Symptoms typically appear in early infancy, often presenting as hypotonia (low muscle tone) and failure to thrive.

What are the common symptoms of MECP2 Duplication Syndrome?

The clinical presentation of MECP2 Duplication Syndrome is complex and impacts multiple body systems, including:

• Neurological: Severe intellectual disability, absent or limited speech, and seizures occurring in approximately 50-75% of patients.


• Physical: Recurrent respiratory infections, which are a major cause of morbidity, and gastrointestinal issues like severe constipation or reflux.


• Developmental: Significant motor delays, with many individuals never achieving independent walking.


• Behavioral: Characteristics often include anxiety, irritability, and autistic-like features.

How is MECP2 Duplication Syndrome diagnosed?

Diagnosis is confirmed through chromosomal microarray (CMA) or targeted genetic testing to detect the copy number variation of the MECP2 gene. Because MECP2 Duplication Syndrome shares features with other developmental disorders, genetic testing is the only way to obtain a definitive diagnosis. Our DiseaseMaps.org community currently supports 12 families navigating the unique challenges of MECP2 Duplication Syndrome, providing a space to share experiences and care strategies.

Next steps

• Consult with a clinical geneticist to discuss testing and family recurrence risks.


• Schedule evaluations with pediatric neurologists, pulmonologists, and gastroenterologists to manage symptoms.


• Join the DiseaseMaps.org community to connect with other families affected by MECP2 Duplication Syndrome.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): MECP2 Duplication Syndrome overview.


• Orphanet: Rare disease database entry for MECP2 duplication.


• OMIM (Online Mendelian Inheritance in Man): Entry #300260.


• International Foundation for MECP2 Duplication Research.